CIK 0001447362 · Accelerated filer
CASTLE BIOSCIENCES INC
Sign in to watch- Ticker
- CSTL
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 770701774
- Phone
- 866-788-9007
- Business address
- 1500 W. PARKWOOD AVE., SUITE 400, FRIENDSWOOD, TX, 77546
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $5,877,844
- in 19 filings, $4.9M under 10b5-1 plans
Net −$5,877,844. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-08-14 | Stokes Frank Chief Financial Officer | Sale | −24,908 | $29.77 | $742K | 35,177 |
| 2026-03-05 | Stokes Frank Chief Financial Officer | Sale 10b5-1 | −6,001 | $27.98 | $168K | 60,085 |
| 2026-03-04 | Stokes Frank Chief Financial Officer | Option exercise 10b5-1 | +24,146 | 73,018 | ||
| 2026-03-04 | Stokes Frank Chief Financial Officer | Shares withheld for taxes 10b5-1 | −10,732 | $28.17 | $302K | 62,286 |
| 2026-03-04 | Stokes Frank Chief Financial Officer | Option exercise 10b5-1 | +3,800 | $3.38 | $13K | 66,086 |
| 2026-03-04 | Stokes Frank Chief Financial Officer | Option exercise · Restricted Stock Units 10b5-1 | −12,186 | 24,372 | ||
| 2026-03-04 | Stokes Frank Chief Financial Officer | Option exercise · Restricted Stock Units 10b5-1 | −11,960 | 35,878 | ||
| 2026-03-04 | Stokes Frank Chief Financial Officer | Option exercise · Stock option (right to buy) 10b5-1 | −3,800 | 14,912 | ||
| 2026-03-03 | Stokes Frank Chief Financial Officer | Sale 10b5-1 | −5,300 | $27.32 | $145K | 54,183 |
| 2026-03-03 | Stokes Frank Chief Financial Officer | Sale 10b5-1 | −1,700 | $27.81 | $47K | 52,483 |
| 2026-03-03 | Stokes Frank Chief Financial Officer | Shares withheld for taxes 10b5-1 | −3,611 | $27.57 | $100K | 48,872 |
| 2026-03-03 | Stokes Frank Chief Financial Officer | Grant or award · Restricted Stock Units 10b5-1 | +48,367 | 48,367 | ||
| 2026-01-12 | Stokes Frank Chief Financial Officer | Grant or award | +8,124 | 58,450 | ||
| 2026-01-12 | Stokes Frank Chief Financial Officer | Grant or award · Performance-Based Stock Unit | +8,124 | 8,124 | ||
| 2025-12-11 | Stokes Frank Chief Financial Officer | Sale | −4,496 | $37.45 | $168K | 50,326 |
| 2025-12-10 | Stokes Frank Chief Financial Officer | Option exercise | +6,170 | 57,580 | ||
| 2025-12-10 | Stokes Frank Chief Financial Officer | Shares withheld for taxes | −2,758 | $38.02 | $105K | 54,822 |
| 2025-12-10 | Stokes Frank Chief Financial Officer | Option exercise · Restricted Stock Units | −6,170 | 0 | ||
| 2025-12-09 | Stokes Frank Chief Financial Officer | Option exercise | +14,616 | 57,944 | ||
| 2025-12-09 | Stokes Frank Chief Financial Officer | Shares withheld for taxes | −6,534 | $38.25 | $250K | 51,410 |
Page 1 of 3 · 47 trades